Actavis, the world's leading general pharmaceutical group and one of the top 50 global pharmaceutical companies, was founded in 1956, headquartered in Switzerland and listed on the stock exchange, is dedicated to the development and sale of general pharmaceuticals, with products in the fields of central nervous, digestive, cardiovascular, metabolic, anti-infective, respiratory and other areas. The company is ranked 858th among the Global 2000 companies in 2014.